[Preference and trends of treatment for diabetic retinopathy in Korea and Japan].

Miho Nozaki, Kiyoshi Suzuma, Makoto Inoue, Ryo Kawasaki, Teruyo Kida, Yoshihiro Takamura, Taiji Nagaoka, Tomoaki Murakami, Shigeo Yoshida, Diabetic Retinopathy Study Group Korea-Japan Diabetic Retinopathy Study Group

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The difference in preferences and trends of treatment in each country are important to plan an international interventional clinical study in eastern Asia. Accordingly, we compared the preferences and trends in treatment of diabetic retinopathy in Korea and Japan. We obtained answers to questionnaires (49 questions) from 91 ophthalmologists of the Korean Retina Society and 120 ophthalmologists of the Japanese Society of Ophthalmic Diabetology in June/July, 2012. Some of the questions were modified from The Preferences and Trends (PAT) survey of American Society of Retina Specialists. The first choice for a patient with vision of 20/25, clinically significant diabetic macular edema and clear evidence of intraretinal fluid on spectral domain OCT were intravitreal anti-vascular endothelial growth factor agent (31%) in Korea and sub-Tenon steroid (22%) in Japan. The management for a patient with refractory neovascular glaucoma who has closed angle and persistent intraocular pressure elevation (>50 mmHg) were glaucoma drainage implant surgery (74%) in Korea and trabeculectomy (57%) in Japan. There were differences in preferences and trends of treatment for diabetic retinopathy between Korea and Japan. The differences need to be considered when planning international clinical studies.

Original languageEnglish
Pages (from-to)735-742
Number of pages8
JournalNippon Ganka Gakkai zasshi
Volume117
Issue number9
Publication statusPublished - Jan 1 2013

Fingerprint

Diabetic Retinopathy
Korea
Japan
Glaucoma Drainage Implants
Neovascular Glaucoma
Trabeculectomy
Macular Edema
Far East
Therapeutics
Intraocular Pressure
Vascular Endothelial Growth Factor A
Retina
Steroids
Ophthalmologists
Clinical Studies
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Nozaki, M., Suzuma, K., Inoue, M., Kawasaki, R., Kida, T., Takamura, Y., ... Korea-Japan Diabetic Retinopathy Study Group, D. R. S. G. (2013). [Preference and trends of treatment for diabetic retinopathy in Korea and Japan]. Nippon Ganka Gakkai zasshi, 117(9), 735-742.

[Preference and trends of treatment for diabetic retinopathy in Korea and Japan]. / Nozaki, Miho; Suzuma, Kiyoshi; Inoue, Makoto; Kawasaki, Ryo; Kida, Teruyo; Takamura, Yoshihiro; Nagaoka, Taiji; Murakami, Tomoaki; Yoshida, Shigeo; Korea-Japan Diabetic Retinopathy Study Group, Diabetic Retinopathy Study Group.

In: Nippon Ganka Gakkai zasshi, Vol. 117, No. 9, 01.01.2013, p. 735-742.

Research output: Contribution to journalArticle

Nozaki, M, Suzuma, K, Inoue, M, Kawasaki, R, Kida, T, Takamura, Y, Nagaoka, T, Murakami, T, Yoshida, S & Korea-Japan Diabetic Retinopathy Study Group, DRSG 2013, '[Preference and trends of treatment for diabetic retinopathy in Korea and Japan].', Nippon Ganka Gakkai zasshi, vol. 117, no. 9, pp. 735-742.
Nozaki M, Suzuma K, Inoue M, Kawasaki R, Kida T, Takamura Y et al. [Preference and trends of treatment for diabetic retinopathy in Korea and Japan]. Nippon Ganka Gakkai zasshi. 2013 Jan 1;117(9):735-742.
Nozaki, Miho ; Suzuma, Kiyoshi ; Inoue, Makoto ; Kawasaki, Ryo ; Kida, Teruyo ; Takamura, Yoshihiro ; Nagaoka, Taiji ; Murakami, Tomoaki ; Yoshida, Shigeo ; Korea-Japan Diabetic Retinopathy Study Group, Diabetic Retinopathy Study Group. / [Preference and trends of treatment for diabetic retinopathy in Korea and Japan]. In: Nippon Ganka Gakkai zasshi. 2013 ; Vol. 117, No. 9. pp. 735-742.
@article{bda16144b39f447988bf742a3a7b57df,
title = "[Preference and trends of treatment for diabetic retinopathy in Korea and Japan].",
abstract = "The difference in preferences and trends of treatment in each country are important to plan an international interventional clinical study in eastern Asia. Accordingly, we compared the preferences and trends in treatment of diabetic retinopathy in Korea and Japan. We obtained answers to questionnaires (49 questions) from 91 ophthalmologists of the Korean Retina Society and 120 ophthalmologists of the Japanese Society of Ophthalmic Diabetology in June/July, 2012. Some of the questions were modified from The Preferences and Trends (PAT) survey of American Society of Retina Specialists. The first choice for a patient with vision of 20/25, clinically significant diabetic macular edema and clear evidence of intraretinal fluid on spectral domain OCT were intravitreal anti-vascular endothelial growth factor agent (31{\%}) in Korea and sub-Tenon steroid (22{\%}) in Japan. The management for a patient with refractory neovascular glaucoma who has closed angle and persistent intraocular pressure elevation (>50 mmHg) were glaucoma drainage implant surgery (74{\%}) in Korea and trabeculectomy (57{\%}) in Japan. There were differences in preferences and trends of treatment for diabetic retinopathy between Korea and Japan. The differences need to be considered when planning international clinical studies.",
author = "Miho Nozaki and Kiyoshi Suzuma and Makoto Inoue and Ryo Kawasaki and Teruyo Kida and Yoshihiro Takamura and Taiji Nagaoka and Tomoaki Murakami and Shigeo Yoshida and {Korea-Japan Diabetic Retinopathy Study Group}, {Diabetic Retinopathy Study Group}",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "117",
pages = "735--742",
journal = "Journal of Japanese Ophthalmological Society",
issn = "0029-0203",
publisher = "Nippon Ganka Gakkai",
number = "9",

}

TY - JOUR

T1 - [Preference and trends of treatment for diabetic retinopathy in Korea and Japan].

AU - Nozaki, Miho

AU - Suzuma, Kiyoshi

AU - Inoue, Makoto

AU - Kawasaki, Ryo

AU - Kida, Teruyo

AU - Takamura, Yoshihiro

AU - Nagaoka, Taiji

AU - Murakami, Tomoaki

AU - Yoshida, Shigeo

AU - Korea-Japan Diabetic Retinopathy Study Group, Diabetic Retinopathy Study Group

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The difference in preferences and trends of treatment in each country are important to plan an international interventional clinical study in eastern Asia. Accordingly, we compared the preferences and trends in treatment of diabetic retinopathy in Korea and Japan. We obtained answers to questionnaires (49 questions) from 91 ophthalmologists of the Korean Retina Society and 120 ophthalmologists of the Japanese Society of Ophthalmic Diabetology in June/July, 2012. Some of the questions were modified from The Preferences and Trends (PAT) survey of American Society of Retina Specialists. The first choice for a patient with vision of 20/25, clinically significant diabetic macular edema and clear evidence of intraretinal fluid on spectral domain OCT were intravitreal anti-vascular endothelial growth factor agent (31%) in Korea and sub-Tenon steroid (22%) in Japan. The management for a patient with refractory neovascular glaucoma who has closed angle and persistent intraocular pressure elevation (>50 mmHg) were glaucoma drainage implant surgery (74%) in Korea and trabeculectomy (57%) in Japan. There were differences in preferences and trends of treatment for diabetic retinopathy between Korea and Japan. The differences need to be considered when planning international clinical studies.

AB - The difference in preferences and trends of treatment in each country are important to plan an international interventional clinical study in eastern Asia. Accordingly, we compared the preferences and trends in treatment of diabetic retinopathy in Korea and Japan. We obtained answers to questionnaires (49 questions) from 91 ophthalmologists of the Korean Retina Society and 120 ophthalmologists of the Japanese Society of Ophthalmic Diabetology in June/July, 2012. Some of the questions were modified from The Preferences and Trends (PAT) survey of American Society of Retina Specialists. The first choice for a patient with vision of 20/25, clinically significant diabetic macular edema and clear evidence of intraretinal fluid on spectral domain OCT were intravitreal anti-vascular endothelial growth factor agent (31%) in Korea and sub-Tenon steroid (22%) in Japan. The management for a patient with refractory neovascular glaucoma who has closed angle and persistent intraocular pressure elevation (>50 mmHg) were glaucoma drainage implant surgery (74%) in Korea and trabeculectomy (57%) in Japan. There were differences in preferences and trends of treatment for diabetic retinopathy between Korea and Japan. The differences need to be considered when planning international clinical studies.

UR - http://www.scopus.com/inward/record.url?scp=84891873281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891873281&partnerID=8YFLogxK

M3 - Article

C2 - 24261188

AN - SCOPUS:84891873281

VL - 117

SP - 735

EP - 742

JO - Journal of Japanese Ophthalmological Society

JF - Journal of Japanese Ophthalmological Society

SN - 0029-0203

IS - 9

ER -